A homozygous PRKN-associated juvenile Parkinson's disease with pregnancy in China

Front Neurol. 2023 Feb 20:14:1103164. doi: 10.3389/fneur.2023.1103164. eCollection 2023.

Abstract

Background: Although Parkinson's disease (PD) is the second most common neurodegenerative disorder, pregnancy in patients with PD is a relatively rare occurrence because the most common age of onset of PD is beyond the childbearing age, except in patients with Young-Onset PD (YOPD) caused by parkin RBR E3 ubiquitin protein ligase (PRKN) mutations.

Case: In this study, we report the case of a 30-year-old Chinese woman who was affected by PRKN-associated YOPD and was treated with levodopa/benserazide during pregnancy. She gave birth to a healthy baby boy with an Apgar score of 9 through an uncomplicated vaginal delivery.

Conclusion: This case further suggests that levodopa/benserazide during pregnancy is safe in the treatment of PRKN-associated YOPD.

Keywords: PRKN gene; Parkinson's disease; levodopa/benserazide; pregnancy; young-onset PD.